Stay updated on Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check10 days agoChange DetectedThe page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check53 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check60 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 15, 2025, while a date of March 25, 2025, has been removed.SummaryDifference1.0%
- Check103 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.